Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Whole-body MRI screening shows promise

This article was originally published in Clinica

Executive Summary

Whole body MRI-screening for disease in asymptomatic patients is technically feasible, but at present should not be performed outside of a research setting until its value has been verified in further settings. So says one of the first studies of its kind to have demonstrated the feasibility of using whole-body MRI to screen for disease. Such examinations are traditionally carried out using computed tomography (CT).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts